Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-24

FDA Approved: BUPROPION HYDROCHLORIDE XL — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental application for Bupropion hydrochloride extended-release (XL), enabling the generic XL product to be marketed i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUPROPION HYDROCHLORIDE XL (BUPROPION HYDROCHLORIDE)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE XL (BUPROPION HYDROCHLORIDE)